Katharina Wohlan

TitlePostdoc Fellows and Associates
InstitutionBaylor College of Medicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Patel TD, Urya H, Guzman AG, Martell AG, Tovy A, Callen E, Murdaugh R, Richard R, Nussenzweig A, Zhang L, Hsu JI, Braekeleer ED, Chen CW, Wohlan K, Waldvogel SM, Jansen S, Vissers L, de Vries BBA, Huang S, Coarfa C, Anastas JN, Takahashi K, Vassiliou G, Goodell MA. SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells. bioRxiv. 2024 Jan 17. PMID: 37693622; PMCID: PMC10491179.
    2. Chambers C, Cermakova K, Chan YS, Kurtz K, Wohlan K, Lewis AH, Wang C, Pham A, Dejmek M, Sala M, Loeza Cabrera M, Aguilar R, Nencka R, Lacorazza HD, Rau RE, Hodges HC. SWI/SNF Blockade Disrupts PU.1-Directed Enhancer Programs in Normal Hematopoietic Cells and Acute Myeloid Leukemia. Cancer Res. 2023 04 04; 83(7):983-996. PMID: 36662812; PMCID: PMC10071820.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    3. Kurtz KJ, Conneely SE, O'Keefe M, Wohlan K, Rau RE. Corrigendum: Murine models of acute myeloid leukemia. Front Oncol. 2022; 12:1089874. PMID: 36911791; PMCID: PMC9997673.
    4. Kurtz KJ, Conneely SE, O'Keefe M, Wohlan K, Rau RE. Murine Models of Acute Myeloid Leukemia. Front Oncol. 2022; 12:854973. PMID: 35756660; PMCID: PMC9214208.
    5. Kirchhoff H, Ricke-Hoch M, Wohlan K, Pietzsch S, Erschow S, Zweigerdt R, Ganser A, Eder M, Scherr M, Hilfiker-Kleiner D, Karsli ?. Chemotherapy-Free Targeted Anti-BCR-ABL+ Acute Lymphoblastic Leukemia Therapy May Benefit the Heart. Cancers (Basel). 2022 Feb 15; 14(4). PMID: 35205731; PMCID: PMC8870618.
    6. Pietzsch S, Wohlan K, Thackeray JT, Heimerl M, Schuchardt S, Scherr M, Ricke-Hoch M, Hilfiker-Kleiner D. Anthracycline-free tumor elimination in mice leads to?functional and molecular cardiac recovery from cancer-induced alterations in contrast to long-lasting doxorubicin treatment effects. Basic Res Cardiol. 2021 10 20; 116(1):61. PMID: 34669013; PMCID: PMC8528750.
      Citations: 4     Fields:    Translation:Animals
    7. Schoenherr C, Wohlan K, Dallmann I, Pich A, Hegermann J, Ganser A, Hilfiker-Kleiner D, Heidenreich O, Scherr M, Eder M. Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase. PLoS One. 2019; 14(12):e0225977. PMID: 31826021; PMCID: PMC6905530.
      Citations: 3     Fields:    Translation:HumansCells
    8. Scherr M, Kirchhoff H, Battmer K, Wohlan K, Lee CW, Ricke-Hoch M, Erschow S, Law E, Kloos A, Heuser M, Ganser A, Hilfiker-Kleiner D, Heidenreich O, Eder M. Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia. Leukemia. 2019 06; 33(6):1313-1323. PMID: 30546081; PMCID: PMC6756054.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    9. Schanda J, Lee CW, Wohlan K, Kunkel H, Coco IQ, Stein S, Koch J, Platzbecker U, Medyouf H, Heuser M, Eder M, Grez M, Scherr M, Wichmann C, M?ller-Kuller U, Metz A, Lausen J, Gohlke H. Suppression of RUNX1/ETO oncogenic activity by a small molecule inhibitor of tetramerization. Haematologica. 2017 05; 102(5):e170-e174. PMID: 28154087; PMCID: PMC5685283.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    10. Lee CW, Wohlan K, Dallmann I, Ganser A, Krueger A, Scherr M, Eder M, Koenecke C, F?rster R. miR-181a Expression in Donor T Cells Modulates Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation. J Immunol. 2016 05 01; 196(9):3927-34. PMID: 27009493.
      Citations: 8     Fields:    Translation:AnimalsCells
    11. Wohlan K, Goy S, Olling A, Srivaratharajan S, Tatge H, Genth H, Gerhard R. Pyknotic cell death induced by Clostridium difficile TcdB: chromatin condensation and nuclear blister are induced independently of the glucosyltransferase activity. Cell Microbiol. 2014 Nov; 16(11):1678-92. PMID: 24898616.
      Citations: 26     Fields:    Translation:HumansCells
    Wohlan's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (71)
    Co-Authors (12)
    Similar People (60)
    Same Department Expand Description